The Development Course of Sihuan Pharmaceutical Co., Ltd.

Sihuan Pharmaceutical Co., Ltd., formerly known as Zhonglian Construction Equipment Co., Ltd., is a joint stock limited company established by 1996 society. 1In August, 1996, the company publicly issued12.5 million shares in Shenzhen Stock Exchange with a share capital of 50 million yuan. 1 In July, 1997, the Beijing Securities Regulatory Commission approved it with the document of Beijing Securities Regulatory License (1997) No.50, and the company adopted the dividend distribution method, and every 10 share was increased to1share, and the share capital was increased to 55 million yuan. 1997 10, with the approval of Beijing Securities Regulatory Commission (1997) No.68, the company adopted dividend distribution and capitalization of capital reserve, and every 10 share was converted into 2 shares and 3 shares, and the share capital increased to 82.5 million yuan.

On June 2, 20001year, the company held the second extraordinary shareholders' meeting in 20001year, and deliberated and passed the Proposal on Assets Replacement between China United Construction Equipment Co., Ltd. and Beijing Sihuan Times Biopharmaceutical Co., Ltd., It is agreed to replace the assets and liabilities of Shandong Crane Factory, a wholly-owned enterprise of China United Construction Equipment Co., Ltd., and other assets and liabilities with those of Beijing Sihuan Times Biopharmaceutical Co., Ltd., and the company's main business will be changed from the manufacturing and sales of hoisting machinery to the research and development of biopharmaceuticals and Chinese and western medicines; Production and sales of small-volume injections and freeze-dried powder injections. On July 4th, 20001year, with the approval of the State Administration for Industry and Commerce, the company was renamed Sihuan Pharmaceutical Co., Ltd.

On June 14, 2006, the second extraordinary shareholders' meeting of the company passed the Proposal on Shareholding Reform by Directional Transfer of Capital Reserve Fund to Shareholders of Circulating Shares. All tradable shareholders increase 5.2 shares for every 10 share, and all tradable shareholders get10,725,000 shares. At this point, the company's total share capital increased to 9322. The company has gone through the industrial and commercial change registration.

65438+On February 26th, 2007, according to the civil ruling (2007)No. 186 issued by the Intermediate People's Court of Weifang City, Shandong Province, Tianjin TEDA Investment Holding Co., Ltd. received 51975,000 shares of the company held by Sihuan Bio-industry Group Co., Ltd., accounting for 55.76% of the company's total share capital, making it the largest company. Sihuan Bio-industry Group Co., Ltd. held another 4,654,380+0,250 shares and transferred them to Wuhan Science and Technology Innovation Biotechnology Co., Ltd.